Anti-VEGF sheep monoclonal antibody - KS Biomedix Holdings
Alternative Names: Anti-VEGF sheep monoclonal antibodyLatest Information Update: 14 May 2001
At a glance
- Originator KS Biomedix Holdings; Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 14 May 2001 Discontinued-Preclinical for Solid tumours in United Kingdom (Unknown route)
- 17 Oct 2000 The sheep monoclonal antibody to vascular endothelial growth factor is available for licensing (http://www.ksbiomedix.com)
- 16 Dec 1997 Preclinical development for Solid tumours in United Kingdom (Unknown route)